Search Results 711-720 of 18372 for Lactation

1. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Patients who are pregnant or lactating; Radiation, chemotherapy, or immunotherapy or any other anticancer therapy ≤ 2 weeks prior to cycle 1 day 1 ...

2. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   Pregnant or lactating patients. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

3. Effect of Secretin on Gastric Accommodation, Emptying and Post-nutrient Challenge Symptoms in Functional Dyspepsia and Healthy Subjects - Mayo Clinic

   Female subjects must have negative urine pregnancy tests and must not be lactating prior to receiving study medication and radiation exposure. For females ...

4. Study Of IBI3020 Treatment In Participants With Late-Stage Solid Tumors - Mayo Clinic

   Women who are pregnant, have positive results in pregnancy test or are lactating; 14. Not eligible to participate in this study at the discretion of the ...

5. PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions - Mayo Clinic

   Pregnant or lactating (to be verbally confirmed with the patient) 3. Life expectancy estimated to be less than three months as determined by patient ...

6. Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG - Mayo Clinic

   Male or non-pregnant, non-lactating female; Females of childbearing potential and all males with partners of childbearing age only if they agree to use ...

7. A Study of TAS-120 in Patients With Metastatic Breast Cancer - Mayo Clinic

   History of another primary malignancy that is currently clinically significant or currently requires active intervention. Pregnant or lactating female ...

8. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

   Pregnant or lactating individuals. Impaired hepatic or renal function as demonstrated by any of the following laboratory values: Aspartate transaminase (AST) ...

9. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   ... lactating/breastfeeding; Previous treatment with emricasan or active investigational medication in a clinical trial within 6 months prior to day 1; Prior ...

10. A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome - Mayo Clinic

    Subject must be male or non-pregnant, non-lactating female, age 2 to 18 years (inclusive); Subject must have documented medical history to support a clinical ...